Post

Acadia Pharmaceuticals begins trial of Alzheimer’s psychosis drug

US-based biotechnology company Acadia Pharmaceuticals has begun a Phase II clinical trial of ACP-204 to treat hallucinations and delusions linked to Alzheimer’s …

TC BioPharm receives FDA approval for AML cell therapy trial

The US Food and Drug Administration (FDA) has granted clearance for TC BioPharm’s investigational new drug (IND) application to begin a …

Roivant and Priovant’s lupus drug fails to meet trial endpoint

Roivant and Priovant have reported that their Phase II clinical trial of oral brepocitinib to treat adults with moderate to severe systemic …

FDA grants IDE to RTI Surgical for breast reconstruction device trial

The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to RTI Surgical’s allograft dermis, opening the …

Post-ventilation study wins Australian Clinical Trial of the Year Award

A clinical trial examining the use of early mobilisation as a treatment for invasively ventilated adults has been awarded Clinical …